-->
/ / / Arthritis drug Humira's two-decade reign ends as Amgen launches competing biosimilar

Arthritis drug Humira's two-decade reign ends as Amgen launches competing biosimilar

The price of Amgen's rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.

     


from USATODAY - News Top Stories https://ift.tt/PrwnTQ9
via